New-onset lung sarcoidosis, an adverse event by COVID-۱۹ or a sign of convalescence; a case report

سال انتشار: 1401
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 104

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CCRMED04_345

تاریخ نمایه سازی: 16 اسفند 1401

چکیده مقاله:

مقدمه :Introduction: Most of the studies in the literature have focused on the management of COVID-۱۹ in the patients suffering from sarcoidosis.هدف :The current report aims to present a COVID-۱۹ induced sarcoidosisمعرفی بیمار :A previously healthy ۴۷-years-old female referred with the chief complaints, including atypical chest pain, dry cough and dyspnea on exertion within a month after COVID-۱۹ infection. Accordingly, a chest computed tomography was performed that revealed multiple conglomerated lymphadenopathies in the thoracic inlet, mediastinum and both hilums. A core-needle biopsy from the nodes was taken that revealed small granulomas composed of epithelioid cells with scattered Lanhans giant cells and lymphocytes. Sarcoidosis diagnosis was proposed and confirmed by negative purified protein derivative (PPD) test. Corticosteroid was initiated and tapered within ۶ months when the symptoms were healed and no pathology was notified in the follow-up imaging.

نویسندگان

Amir Aria

Department of Internal Medicine, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Mahnaz Momenzadeh

Department of Clinical Pharmacy And Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran

Somayeh Sadeghi

Department of Internal Medicine, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Shadi Reisizadeh Mobarakeh

Department of Internal Medicine, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran